Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Antineoplastic Combined Chemotherapy Protocols
Interventions: DRUG: Pegylated Liposomal Doxorubicin|DRUG: Cyclophosphamide|DRUG: Taxotere|DRUG: Dexrazoxane (DZR)|DRUG: vitamin B|DRUG: Doxorubicin|PROCEDURE: Breast Conserved Surgery|PROCEDURE: Modified Radical Mastectomy|PROCEDURE: Sentinel Lymph Node Biopsy（SLNB）
Sponsor: Jilin University